A Multicenter, Randomized, Double-Blind, Double-Dummy , Pregaballin-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of HSK16149 Capsules in Chinese Patients With Herpetic Neuralgia
Latest Information Update: 14 Nov 2023
At a glance
- Drugs Crisugabalin (Primary) ; Pregabalin
- Indications Neuralgia
- Focus Therapeutic Use
- Sponsors Haisco Pharmaceutical Group
Most Recent Events
- 07 Nov 2023 Status changed from recruiting to completed.
- 13 Mar 2023 New trial record